Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Open Access
- 2 April 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (4), e1867
- https://doi.org/10.1371/journal.pone.0001867
Abstract
Misfolding, oligomerization, and fibrillization of α-synuclein are thought to be central events in the onset and progression of Parkinson's disease (PD) and related disorders. Although fibrillar α-synuclein is a major component of Lewy bodies (LBs), recent data implicate prefibrillar, oligomeric intermediates as the toxic species. However, to date, oligomeric species have not been identified in living cells. Here we used bimolecular fluorescence complementation (BiFC) to directly visualize α-synuclein oligomerization in living cells, allowing us to study the initial events leading to α-synuclein oligomerization, the precursor to aggregate formation. This novel assay provides us with a tool with which to investigate how manipulations affecting α-synuclein aggregation affect the process over time. Stabilization of α-synuclein oligomers via BiFC results in increased cytotoxicity, which can be rescued by Hsp70 in a process that reduces the formation of α-synuclein oligomers. Introduction of PD-associated mutations in α-synuclein did not affect oligomer formation but the biochemical properties of the mutant α-synuclein oligomers differ from those of wild type α-synuclein. This novel application of the BiFC assay to the study of the molecular basis of neurodegenerative disorders enabled the direct visualization of α-synuclein oligomeric species in living cells and its modulation by Hsp70, constituting a novel important tool in the search for therapeutics for synucleinopathies.Keywords
This publication has 31 references indexed in Scilit:
- α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular ProtofibrilsJournal of Molecular Biology, 2002
- Genetics of Parkinson's disease and biochemical studies of implicated gene products: CommentaryCurrent Opinion in Cell Biology, 2002
- Annular α-Synuclein Protofibrils Are Produced When Spherical Protofibrils Are Incubated in Solution or Bound to Brain-Derived MembranesBiochemistry, 2002
- Visualization of Interactions among bZIP and Rel Family Proteins in Living Cells Using Bimolecular Fluorescence ComplementationMolecular Cell, 2002
- Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's DiseaseScience, 2002
- α-Synuclein–enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neuronsNeuroscience, 2001
- Parkinsons Disease and other α-Synucleinopathiescclm, 2001
- Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein MutantsAnnals of the New York Academy of Sciences, 2000
- Alpha-synuclein and Parkinson's diseaseCellular and Molecular Life Sciences, 2000
- Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapyProceedings of the National Academy of Sciences of the United States of America, 2000